Discover trends, market shifts, and competitive outlooks for the methenamine hippurate tablets industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#How Has The Methenamine Hippurate Tablets Market Growth Evolved From 2024 To 2025, And What’s Ahead?

In the past few years, the market for methenamine hippurate tablets has seen substantial growth. The market is set to expand from $9.52 billion in 2024 to $10.21 billion in 2025, growing at a compound annual growth rate (CAGR) of 7.2%. The significant growth observed in the historical period is attributed to factors such as the conventional UTI treatment, concerns regarding antibiotic resistance, clinical validation, the prescription habits of physicians, and the patient’s preference for non-antibiotic solutions.

The market for methenamine hippurate tablets is projected to witness substantial expansion in the coming years. It is estimated to reach a value of $13.78 billion by 2029, with a compound annual growth rate (CAGR) of 7.8%. This surge over the forecast period can be associated with the increased prevalence of UTIs, growing concerns over antibiotic resistance, improvements in UTI treatment approaches, emphasis on preventative health measures, and ongoing clinical trials and research. Key trends anticipated during this forecast period include a surge in UTI cases, escalation in antibiotic resistance, a preference for treatments not relying on antibiotics, concentration on preventative healthcare, and continued research and development.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9412&type=smp

What Are the Major Market Drivers Behind the Rising Adoption of Methenamine Hippurate Tablets Market?

The escalation in the elderly population is projected to propel the advancement of the methenamine hippurate tablets market in the future. The term elder population is used to represent people who are aged 60 or more. Older patients are more prone to urinary tract infections as a result of various reasons such as slowed urine flow, an expanded prostate, or kidney stones, therefore necessitating methenamine hippurate tablets for treatment. For example, the World Health Organization, a Switzerland-based UN agency that focuses on global public health, has revealed that by 2030, one out of every six people will be 60 or older. In 2022, the number of individuals over the age of 60 was 1.4 billion. The count of people aged 60 or more worldwide is anticipated to double by 2050 (2.1 billion), while those over 80 years old will see a threefold increase, reaching 426 million. Hence, the growing older population fuels the expansion of the methenamine hippurate tablets market.

Which Key Market Segments Comprise the Methenamine Hippurate Tablets Market and Drive Its Revenue Growth?

The methenamine hippurate tablets market covered in this report is segmented –

1) By Type: 20 Tablets Or Bottle, 6 Tablets Or Bottle

2) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

3) By Application: Uncomplicated UTIs, Healthcare-associated UTIs

4) By End User: Hospitals, Homecare, Specialty Clinics, Others End Users

Subsegments:

1) By 20 Tablets per Bottle: Standard Packaging, Bulk Packaging Options

2) By 6 Tablets per Bottle: Standard Packaging, Sample Or Trial Packaging

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=9412&type=smp

Which Areas Are Leading Regions in the Methenamine Hippurate Tablets Market Expansion Across the Globe?

North America was the largest region in the methenamine hippurate tablets market in 2024. The regions covered in the methenamine hippurate tablets market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Are the Strategic Trends Steering theMethenamine Hippurate Tablets Market Direction?

The rise of product innovations is a noteworthy trend escalating in the methenamine hippurate tablets market. Large firms active in this sector are creating innovative items to solidify their market stance. For example, EQL Pharma, a Europe-based pharmaceutical firm specializing in cost-effective generic and niche generic drugs for pharmacies and hospitals, declared the out-licensing of Memprex (methenamine hippurate) to Laboratoires Majorelle in May 2023. This move aims to broaden its reach in the French market and offer a non-antibiotic alternative for UTI prevention. Laboratoires Majorelle, a distinguished women’s health company in France, will market and distribute Memprex, expanding the choices for non-antibiotic UTI prevention.

View the full report here:

https://www.thebusinessresearchcompany.com/report/methenamine-hippurate-tablets-global-market-report

How Is the Methenamine Hippurate Tablets Market Conceptually Defined?

Methenamine Hippurate Tablets refer to a medication primarily used as an antimicrobial agent. It is used to prevent and treat urinary tract infections (UTIs) by creating an acidic environment in the urine, which inhibits bacterial growth. This medication is often prescribed for patients with recurrent UTIs to reduce the frequency of infections.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9412

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model